{
  "docId": "019de073-dba4-758b-bcbe-08ad83e87d71",
  "docSlug": "afc13b14322819221680611098a4aee7",
  "documentTitle": "Third Harmonic Bio | Investor Presentation Deck | 20 slides",
  "authorId": "third-harmonic-bio",
  "authorName": "Third Harmonic Bio",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 20,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 4,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-dba4-758b-bcbe-08ad83e87d71/6",
  "deckHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71",
  "deckJsonHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71.json",
  "deckAnchorHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.285,
        "w": 0.323,
        "x": 0.065,
        "y": 0.305
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "42ee3efb-e8a1-4ba4-889b-449c745d8a4e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.272,
        "w": 0.323,
        "x": 0.065,
        "y": 0.612
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f5c53a3e-7016-484a-be82-8c5e9fb58c4e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.56,
        "w": 0.58,
        "x": 0.382,
        "y": 0.318
      },
      "kind": "list",
      "text": "Prevalence: ~5-10% of all asthma patients; estimated 750K – 1 million patients in US; adult population ~60% female, mean age ~50 years\nDefinition: disease not sufficiently controlled with standard nonbiologic treatments; reduced lung function, higher incidence of exacerbations\nMast cells shown to play a central role: in both regulation of both lower airway inflammation and airway hyperresponsiveness\nCurrent oral treatment options are limited: multiple approved biologics, but no new oral therapy approved for asthma since anti-leukotrienes in late 1990s\nNew oral treatment options with the potential to treat across all severe asthma endotypes are needed",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e7e4e7cd-1aea-4bd1-8cc2-5b6c69a4d36d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.73,
        "x": 0.036,
        "y": 0.128
      },
      "kind": "title",
      "text": "Limited oral treatment options for patients beyond corticosteroids and anti-leukotrienes",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3995471-a94b-4860-9f0f-8f57c9eff987",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.43,
        "x": 0.036,
        "y": 0.068
      },
      "kind": "title",
      "text": "Severe Asthma Disease Overview",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a5e3253-cde7-492e-a997-36b9a94baad9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 4,
      "beatId": "9bbcdd02-ea61-4d50-b4e2-4ad81a367cfa",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "Slides 4-6 provide an overview of the problem, including Chronic Urticaria and Severe Asthma",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "d0bcbc72-d25a-48fc-b81f-8973015fd45d",
      "evidence": "Slides 4-6 provide an overview of the problem, including Chronic Urticaria and Severe Asthma",
      "position": 0,
      "objective": "What is the cost of not treating mast cell-mediated diseases?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}